Table 1.
General medical conditions | Total Sample | Respondents without lifetime PEs | Respondents with lifetime PEs | Respondents endorsing both lifetime GMC and PE | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||||||||
PEs prior to GMC onset | GMC in the same year as PEs onset | GMC prior to PEs onset | Goodness-of-fit test for equal proportiona | |||||||||||||||||
|
|
|
|
|
|
|
||||||||||||||
n | %b | SE | n | %b | SE | n | %b | SE | n | %b | SE | n | %b | SE | n | %b | SE | χ21 | p-value | |
Arthritis | 5640 | 18·1 | 0·4 | 5132 | 17·7 | 0·4 | 508 | 26·1 | 1·4 | 308 | 61·0 | 3·6 | 22 | 4·2 | 1·3 | 178 | 34·9 | 3·4 | 22·5* | <·0001 |
Back or neck pain | 7839 | 24·3 | 0·4 | 7043 | 23·6 | 0·4 | 796 | 38·3 | 1·7 | 439 | 55·7 | 2·9 | 32 | 4·1 | 1·1 | 325 | 40·2 | 2·7 | 14·8* | 0·0001 |
Frequent or severe headaches | 6701 | 19·3 | 0·4 | 5958 | 18·5 | 0·4 | 743 | 34·1 | 1·5 | 324 | 43·9 | 2·6 | 55 | 7·0 | 1·3 | 364 | 49·1 | 2·7 | 2·1 | 0·1475 |
Other chronic pain | 2527 | 7·1 | 0·2 | 2152 | 6·6 | 0·2 | 375 | 17·0 | 1·3 | 213 | 57·8 | 4·0 | 12 | 4·0 | 1·4 | 150 | 38·2 | 3·9 | 11·1* | 0·0008 |
Heart disease | 1949 | 6·3 | 0·2 | 1791 | 6·2 | 0·2 | 158 | 9·1 | 1·1 | 103 | 72·6 | 5·4 | 7 | 5·9 | 2·2 | 48 | 21·5 | 5·2 | 32·0* | <·0001 |
High blood pressure | 4808 | 15·4 | 0·3 | 4372 | 15·1 | 0·3 | 436 | 21·2 | 1·4 | 306 | 69·3 | 3·2 | 21 | 4·2 | 1·1 | 109 | 26·6 | 3·1 | 201·8* | <·0001 |
Asthma | 2397 | 7·8 | 0·2 | 2103 | 7·5 | 0·2 | 294 | 15·0 | 1·3 | 105 | 31·3 | 3·9 | 15 | 4·6 | 1·6 | 174 | 64·2 | 4·1 | 68·8* | <·0001 |
Diabetes | 1463 | 4·6 | 0·2 | 1331 | 4·5 | 0·2 | 132 | 6·1 | 0·8 | 97 | 80·8 | 4·3 | 4 | 2·4 | 1·6 | 31 | 16·8 | 4·0 | -c | -c |
Peptic ulcer | 1826 | 5·5 | 0·2 | 1622 | 5·3 | 0·2 | 204 | 9·5 | 0·9 | 123 | 62·6 | 4·9 | 8 | 2·1 | 0·8 | 73 | 35·3 | 4·8 | 60·2* | <·0001 |
Cancer | 868 | 2·9 | 0·1 | 759 | 2·8 | 0·1 | 109 | 4·5 | 0·5 | 75 | 68·2 | 5·9 | 4 | 3·0 | 1·8 | 30 | 28·8 | 5·8 | 91·6* | <·0001 |
Other chronic lung diseases | 435 | 1·3 | 0·1 | 387 | 1·3 | 0·1 | 48 | 2·0 | 0·6 | 32 | 73·8 | 9·6 | 2 | 3·6 | 2·8 | 14 | 22·6 | 9·0 | 13·4* | 0·0003 |
Stroke | 467 | 2·0 | 0·1 | 415 | 1·9 | 0·1 | 52 | 2·5 | 0·5 | 39 | 77·1 | 7·6 | 4 | 6·9 | 4·4 | 9 | 16·0 | 6·4 | 110·5* | <·0001 |
SE, standard error
Significant at the ·05 level, 2-sided test.
Chi square tests comparing the proportion of respondents with PE onset prior to GMC onset versus the proportion of respondents with GMC onset prior to PE onset.
Estimates are based on weighted data.
Unstable estimates due to small design effect.